Drug–Drug Interactions in Intensive Care Unit (ICU): A Review
This review article provides an overview of drug–drug interactions (DDIs) in Intensive Care Units (ICUs). It discusses the prevalence, mechanisms, risk factors, commonly involved drug combinations, clinical consequences, and strategies for prevention and management. The article highlights the importance of medication review, clinical pharmacist involvement, and multidisciplinary collaboration to improve patient safety and optimize therapeutic outcomes in critically ill patients. This work is intended for educational and research purposes.
Authors
- Tasin Ahmed
Institutions
- University of Information Technology and Sciences (BD)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-07-23
- DOI
- https://doi.org/10.5281/zenodo.21514638
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- preprint